REQUEST A DEMO
Total
USD $0.00
Search more companies

Siti Pharma Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Siti Pharma Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Siti Pharma Sdn. Bhd. is a company based in Malaysia, with its head office in Putrajaya. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on December 04, 2018. In 2022, the company reported a net sales revenue increase of 674226550%. Over the same period, its total assets grew by 173225.23%.

Headquarters
M-3-03 (3Rd Floor), Conezion, Persiaran Irc 3,, Ioi Resort City
Putrajaya; Putrajaya; Postal Code: 62502

Contact Details: Purchase the Siti Pharma Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Siti Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Siti Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
December 04, 2018
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Siti Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
674226550%
Total operating revenue
674226550%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
173225.23%
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
22.62%
Quick Ratio
1.02%
Cash Ratio
-0.34%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?